Home » Stocks » LCI

Lannett Company, Inc. (LCI)

Stock Price: $4.43 USD -0.02 (-0.45%)
Updated May 7, 2021 4:00 PM EDT - Market closed
Market Cap 184.24M
Revenue (ttm) 510.69M
Net Income (ttm) -195.29M
Shares Out 39.51M
EPS (ttm) -4.99
PE Ratio n/a
Forward PE 12.92
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $4.43
Previous Close $4.45
Change ($) -0.02
Change (%) -0.45%
Day's Open 4.41
Day's Range 4.40 - 4.64
Day's Volume 358,132
52-Week Range 4.21 - 10.70

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Lannett (LCI) delivered earnings and revenue surprises of 140.00% and -2.35%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

3 days ago - Zacks Investment Research

PHILADELPHIA, May 5, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2021 third quarter ended March 31, 2021.  "In recent months, we have significa...

4 days ago - PRNewsWire

Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago - Zacks Investment Research

PHILADELPHIA, April 28, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2021 third quarter on Wednesday, May 5, 2021, after th...

1 week ago - PRNewsWire

PHILADELPHIA, April 22, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced the closing of the $350 million aggregate principal amount of 7.750% senior secured notes due 2026 (the "No...

2 weeks ago - PRNewsWire

PHILADELPHIA, April 9, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) (the "Company" or "Lannett") today announced the pricing of the $350 million aggregate principal amount of 7.75% senior secu...

1 month ago - PRNewsWire

PHILADELPHIA, April 6, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) (the "Company") today announced that it intends to offer, subject to market conditions and other factors, $350 million aggre...

1 month ago - PRNewsWire

PHILADELPHIA, April 1, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced the submission of an Abbreviated New Drug Application (ANDA) for Fluticasone propionate and Salmeterol inhal...

1 month ago - PRNewsWire

New York, New York--(Newsfile Corp. - March 21, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Lannett Company, Inc. ("Lannett" or the "Company") (NYSE: LCI). Such investors are...

1 month ago - Newsfile Corp

NEW YORK, March 12, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Lannett Company, Inc. ("Lannett" or the "Company") (NYSE: LCI). Such investors are advised to co...

1 month ago - PRNewsWire

PHILADELPHIA, March 10, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it recently received feedback from the U.S. Food and Drug Administration (FDA) regarding biosimilar in...

1 month ago - PRNewsWire

New York, New York--(Newsfile Corp. - March 7, 2021) -  Pomerantz LLP is investigating claims on behalf of investors of Lannett Company, Inc. ("Lannett" or the "Company") (NYSE: LCI). Such investors are...

2 months ago - Newsfile Corp

PHILADELPHIA, Feb. 8, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has begun marketing Chlorpromazine Hydrochloride Tablets, USP, 10 mg, 25 mg, 50 mg, 100 mg and 200 mg...

3 months ago - PRNewsWire

Investors are not impressed with the company's full-year guidance.

3 months ago - The Motley Fool

Lannett (LCI) delivered earnings and revenue surprises of 0.00% and 2.95%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

PHILADELPHIA, Feb. 3, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2021 second quarter ended December 31, 2020. "For the fiscal 2021 second quar...

3 months ago - PRNewsWire

The movement of retail traders against hedge funds has caused several stocks to spike. Many of the top movers have been stocks that have a high percentage of their floated shares short, causing what's k...

Other stocks mentioned: CLVS, DVAX, NAKD, OPK, PGEN, SENS, TXMD ...
3 months ago - Benzinga

PHILADELPHIA, Jan. 27, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2021 second quarter on Wednesday, February 3, 2021, aft...

3 months ago - PRNewsWire

PHILADELPHIA, Dec. 7, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced the closing of a $30 million asset-backed revolving credit facility with Wells Fargo Bank, National Associati...

5 months ago - PRNewsWire

PHILADELPHIA, Nov. 30, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that the company used a portion of its existing cash on hand to pay off, in full, the remaining $42 million ...

5 months ago - PRNewsWire

Let's see if Lannett Company (LCI) stock is a good choice for value-oriented investors right now from multiple angles.

5 months ago - Zacks Investment Research

Lannett (LCI) delivered earnings and revenue surprises of -45.45% and -2.63%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Lannett Company, Inc. (LCI) CEO Tim Crew on Q1 2021 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

PHILADELPHIA, Nov. 4, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2021 first quarter ended September 30, 2020. "We view our fiscal 2021 first q...

6 months ago - PRNewsWire

Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

PHILADELPHIA, Pa., Oct. 28, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2021 first quarter on Wednesday, November 4, 2020,...

6 months ago - PRNewsWire

Better-than-expected top and bottom lines weren't enough to make investors happy for one key reason.

8 months ago - The Motley Fool

Lannett Company, Inc. (LCI) CEO Tim Crew on Q4 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Earnings season has been winding down this week, but there are always some companies still reporting or offering guidance.

Other stocks mentioned: BOX, NTAP, SPLK, WSM
8 months ago - 24/7 Wall Street

Shares of Lannett (NYSE:LCI) moved lower by 7.6% in after-market trading after the company reported Q4 results.

8 months ago - Benzinga

PHILADELPHIA, Aug. 26, 2020 /PRNewswire/ -- Lannett Company, Inc.

8 months ago - PRNewsWire

On Wednesday, August 26, Lannett (NYSE: LCI) will release its latest earnings report.

8 months ago - Benzinga

PHILADELPHIA, Aug. 19, 2020 /PRNewswire/ -- Lannett Company, Inc.

8 months ago - PRNewsWire

PHILADELPHIA, Aug. 17, 2020 /PRNewswire/ -- Lannett Company, Inc.

8 months ago - PRNewsWire

PHILADELPHIA, Aug. 17, 2020 /PRNewswire/ -- Lannett Company, Inc.

8 months ago - PRNewsWire

Lannett: Market Is Pricing The Worst Scenario, Why We Remain Invested

9 months ago - Seeking Alpha

Investors responded enthusiastically to the company's new generic distribution deal.

9 months ago - The Motley Fool

Shares of Lannett Company Inc. LCI, -7.12% gained 0.2% after the company said it will cut 80 positions, about 8.5% of its total workforce, over concerns that its generic fluphenazine product will face c...

9 months ago - Market Watch

PHILADELPHIA, July 13, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced a restructuring and cost savings plan. The initiatives include consolidating the research and development (R...

9 months ago - PRNewsWire

PHILADELPHIA, June 11, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today said that representatives from the company spoke with and received guidance from the U.S. Food and Drug Administration...

10 months ago - PRNewsWire

Here's why a new initiative by the FDA to reduce drug prices is great for patients but should raise the alarm among pharmaceutical investors.

Other stocks mentioned: ANIP, MYL, PFE, TARO, TEVA
11 months ago - The Motley Fool

The company released its earnings report for the third quarter of its fiscal year 2020.

1 year ago - The Motley Fool

Lannett Company, Inc. (LCI) CEO Timothy Crew on Q3 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Lannett (LCI) delivered earnings and revenue surprises of 3.85% and 8.18%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

The generic-drug maker's revenue and earnings fell in Q2. But there were still several positives in Lannett's quarterly update.

1 year ago - The Motley Fool

Lannett Company, Inc.'s (LCI) CEO Tim Crew on Q2 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Lannett (LCI) delivered earnings and revenue surprises of 0.00% and 5.82%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Lannett (LCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

Elite is on track to become profitable for the first time

Other stocks mentioned: ATNX
1 year ago - Seeking Alpha

About LCI

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular,... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
Founded
1942
CEO
Timothy Crew
Employees
954
Stock Exchange
NYSE
Ticker Symbol
LCI
Full Company Profile

Financial Performance

In 2020, LCI's revenue was $545.74 million, a decrease of -16.73% compared to the previous year's $655.41 million. Losses were -$33.37 million, -87.74% less than in 2019.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for LCI stock is "Hold." The 12-month stock price forecast is 5.88, which is an increase of 32.73% from the latest price.

Price Target
$5.88
(32.73% upside)
Analyst Consensus: Hold